References in periodicals archive ?
M2 EQUITYBITES-July 23, 2013-NanoViricidesa[euro](tm) Orphan Drug Designation application for DengueCide to be reviewed by clinical coordinators by Committee on Orphan Medicinal Products of EMA(C)2013 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-July 23, 2013-NanoViricidesa[euro](tm) Orphan Drug Designation application for DengueCide to be reviewed by clinical coordinators by Committee on Orphan Medicinal Products of EMA(C)2013 M2 COMMUNICATIONS
The Agency's scientific opinions are drawn up by three committees responsible for human medicines (Committee on Proprietary Medicinal Products, CPMP), veterinary medicines (Committee on Veterinary Medicinal Products, CVMP) and so-called "orphan" medicines for rare diseases (Committee on orphan medicinal products, COMP).

Full browser ?